{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:34Z","timestamp":1792807534416,"version":"4.5.0"},"reference-count":141,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>In recent years, bacterial resistance to conventional antibiotics has become a major concern in the medical field. The global misuse of antibiotics in clinics, personal use, and agriculture has accelerated this resistance, making infections increasingly difficult to treat and rendering new antibiotics ineffective more quickly. Finding new antibiotics is challenging due to the complexity of bacterial mechanisms, high costs and low financial incentives for the development of new molecular scaffolds, and stringent regulatory requirements. Additionally, innovation has slowed, with many new antibiotics being modifications of existing drugs rather than entirely new classes. Antimicrobial peptides (AMPs) are a valid alternative to small-molecule antibiotics offering several advantages, including broad-spectrum activity and a lower likelihood of inducing resistance due to their multifaceted mechanisms of action. However, AMPs face challenges such as stability issues in physiological conditions, potential toxicity to human cells, high production costs, and difficulties in large-scale manufacturing. A reliable strategy to overcome the drawbacks associated with the use of small-molecule antibiotics and AMPs is combination therapy, namely the simultaneous co-administration of two or more antibiotics or the synthesis of covalently linked conjugates. This review aims to provide a comprehensive overview of the literature on the development of antibiotic\u2013AMP conjugates, with a particular emphasis on critically analyzing the design and synthetic strategies employed in their creation. In addition to the synthesis, the review will also explore the reported antibacterial activity of these conjugates and, where available, examine any data concerning their cytotoxicity.<\/jats:p>","DOI":"10.3390\/antibiotics13080783","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T04:48:25Z","timestamp":1724647705000},"page":"783","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dual Antibiotic Approach: Synthesis and Antibacterial Activity of Antibiotic\u2013Antimicrobial Peptide Conjugates"],"prefix":"10.3390","volume":"13","author":[{"given":"Maria Cristina","family":"Bellucci","sequence":"first","affiliation":[{"name":"Department of Food, Environmental, and Nutritional Sciences, Universit\u00e0 degli Studi di Milano, Via Celoria 2, 20131 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5041-6743","authenticated-orcid":false,"given":"Carola","family":"Romani","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Materials, and Chemical Engineering \u201cGiulio Natta\u201d, Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sani","sequence":"additional","affiliation":[{"name":"Consiglio Nazionale delle Ricerche, Istituto di Scienze e Tecnologie Chimica \u201cG. Natta\u201d (SCITEC), Via Mario Bianco 9, 20131 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-0744","authenticated-orcid":false,"given":"Alessandro","family":"Volonterio","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Materials, and Chemical Engineering \u201cGiulio Natta\u201d, Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/S1473-3099(18)30513-9","article-title":"Analysis of the clinical antibacterial and antituberculosis pipeline","volume":"19","author":"Theuretzbacher","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/jac\/dkv484","article-title":"Antibiotics: From prehistory to the present day","volume":"71","author":"Gould","year":"2016","journal-title":"J. Antimocrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Christensen, S.B. (2021). Drugs that changed society: History and current status of the early antibiotics: Salvarsan, sulfonamides, and b-lactams. Molecules, 26.","DOI":"10.3390\/molecules26196057"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Baran, A., Kwiatkowska, A., and Potocki, L. (2023). Antibiotics and bacterial resistance\u2014A short story of an endless arms race. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065777"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Halawa, E.M., Fadel, M., Al-Rabia, M.W., Behairy, A., Nouh, N.A., Abdo, M., Olga, R., Fericean, L., Atwa, A.M., and El-Nablaway, M. (2024). Antibiotic action and resistance: Updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1305294"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and Evolution of Antibiotic Resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","article-title":"Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects","volume":"12","author":"Uddin","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41579-022-00820-y","article-title":"Molecular mechanisms of antibiotic resistance revisited","volume":"21","author":"Darby","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/phar.1636","article-title":"Infections caused by resistant gram-negative bacteria: Epidemiology and management","volume":"35","author":"Kaye","year":"2015","journal-title":"Pharmacotherapy"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4155\/fmc-2021-0009","article-title":"Novel strategies in the war against antibiotic resistance","volume":"13","author":"Cascioferro","year":"2021","journal-title":"Future Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: Confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd4572","article-title":"ESKAPEing the labyrinth of antibacterial discovery","volume":"14","author":"Tommasi","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/jm700967e","article-title":"Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery","volume":"51","author":"Moser","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1070\/RCR4892","article-title":"Main trends in the design of semi-synthetic antibiotics of a new generation","volume":"89","author":"Olsufyeva","year":"2020","journal-title":"Russ. Chem. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1039\/C7NP00019G","article-title":"Opportunities for natural products in 21st-century antibiotic discovery","volume":"34","author":"Wright","year":"2017","journal-title":"Nat. Prod. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/ja.2015.98","article-title":"A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics","volume":"69","author":"Renwick","year":"2016","journal-title":"J. Antibiot."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1377\/hlthaff.2014.1003","article-title":"Repairing the broken market for antibiotic innovation","volume":"34","author":"Outterson","year":"2015","journal-title":"Health Aff."},{"key":"ref_20","first-page":"277","article-title":"The antibiotic resistance crisis: Part 1: Causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Shi, Z., Zhang, J., Tia, L., Xin, L., Liang, C., Ren, X., and Li, M. (2023). A comprehensive overview of the antibiotics approved in the last two decades: Retrospects and prospects. Molecules, 28.","DOI":"10.3390\/molecules28041762"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Murugaiyan, J., Kumar, P.A., Rao, G.S., Iskandar, K., Hawser, S., Hays, J.P., Moshen, Y., Adukkadukkam, S., Awuah, W.A., and Jose, R.A.M. (2022). Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics, 11.","DOI":"10.3390\/antibiotics11020200"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: Synergy, rejuvenation, and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert. Rev. Anti-Infect. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mib.2020.05.012","article-title":"How antibiotics work together: Molecular mechanisms behind combination therapy","volume":"57","author":"Sullivan","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mib.2021.09.006","article-title":"Leveraging laboratory and clinical studies to design effective antibiotic combination therapy","volume":"64","author":"Davis","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"19470","DOI":"10.1039\/D2RA03281C","article-title":"Design and synthesis of hybrid compounds as novel drugs and medicines","volume":"12","author":"Alkhzem","year":"2022","journal-title":"RSC Adv."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cavaco, M., Castanho, M.A.R.B., and Neves, V. (2022). The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.835677"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"17","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"123169","DOI":"10.1016\/j.ijpharm.2023.123169","article-title":"No country for old antibiotics! Antimicrobial peptides (AMP) as next-generation treatment for skin and soft tissue infection","volume":"642","author":"Raileanu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1381612820666140905124312","article-title":"Potential application of antimicrobial peptides in the treatment of bacterial biofilm infections","volume":"21","author":"Strempel","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2174\/1568026619666181129141524","article-title":"Antibiotics-peptide conjugates: Against multidrug-resistant bacterial pathogens","volume":"18","author":"David","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e02340-16","DOI":"10.1128\/AAC.02340-16","article-title":"Intracellular targeting mechanisms by antimicrobial peptides","volume":"61","author":"Le","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Hadjicharalambous, A., Bournakas, N., Newman, H., Skynner, M.J., and Beswick, P. (2022). Antimicrobial and cell-penetrating peptides: Understanding penetration for the design of novel conjugate antibiotics. Antibiotics, 11.","DOI":"10.3390\/antibiotics11111636"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/sextrans-2014-051779","article-title":"Magic bullet: Paul Ehrlich, Salvarsan and the birth of venereology","volume":"91","author":"Gelpi","year":"2015","journal-title":"Sex. Transm. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0025727300040758","article-title":"New light on the history of penicillin","volume":"26","author":"Hare","year":"1982","journal-title":"Med. Hist."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ja.2013.49","article-title":"Prospects for new antibiotics: A molecule-centered perspective","volume":"67","author":"Walsh","year":"2014","journal-title":"J. Antibiot."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.chemosphere.2013.11.038","article-title":"Biocompatibility and antibacterial activity of photolytic products of sulfonamides","volume":"100","author":"Zessel","year":"2014","journal-title":"Chemosphere"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.2174\/1389557520666200905125738","article-title":"From Antibacterial to Antitumour Agents: A Brief Review on The Chemical and Medicinal Aspects of Sulfonamides","volume":"20","author":"Dias","year":"2020","journal-title":"Mini-Rev. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"112829","DOI":"10.1016\/j.ejmech.2020.112829","article-title":"\u03b2-Lactam antibiotics: An overview from a medicinal chemistry perspective","volume":"208","author":"Lima","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Yocum, R.R., Rasmussen, J.R., and Strominger, J.L. (1980). The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. J. Biol. Chem., 255.","DOI":"10.1016\/S0021-9258(19)85621-1"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/S0021-9258(19)85620-X","article-title":"Sequence of active site peptides from the penicillin-sensitive D-alanine carboxypeptidase of Bacillus subtilis. Mechanism of penicillin action and sequence homology to beta-lactamases","volume":"255","author":"Waxman","year":"1980","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1179\/joc.2003.15.6.525","article-title":"Resistance to \u03b2-Lactams\u2014The Permutations","volume":"15","author":"Amyes","year":"2003","journal-title":"J. Chemother."},{"key":"ref_43","first-page":"11","article-title":"Can \u03b2-lactams be re-engineered to beat MRSA?","volume":"12","author":"Livermore","year":"2006","journal-title":"CMI"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, S., Liao, Y.X., Ding, T., and Ahn, J. (2023). Role of \u03b2-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria. Antibiotics, 13.","DOI":"10.3390\/antibiotics13030260"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00594-16","article-title":"rRNA binding sites and the molecular mechanism of action of the tetracyclines","volume":"60","author":"Chukwudi","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1080\/07853890.2022.2085881","article-title":"Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance","volume":"54","author":"LaPlante","year":"2022","journal-title":"Ann. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Davies, J., and Wright, G.D. (1997). Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol., 5.","DOI":"10.1016\/S0966-842X(97)01033-0"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/cbic.200900779","article-title":"The future of aminoglycosides: The end or renaissance?","volume":"11","author":"Houghton","year":"2010","journal-title":"ChemBioChem"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/wrna.60","article-title":"Antibiotics that target protein synthesis","volume":"2","author":"McCoy","year":"2011","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1093\/nar\/gki862","article-title":"Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: Role of the number of rings and positive charges in the specific binding leading to miscoding","volume":"33","author":"Russell","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nchembio.274","article-title":"Aminoglycoside activity observed on single pre-translocation ribosome complexes","volume":"6","author":"Feldman","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C5MD00344J","article-title":"Mechanisms of resistance to aminoglycoside antibiotics: Overview and perspectives","volume":"7","author":"Labby","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1039\/C6MD00079G","article-title":"Structural modifications of the neomycin class of aminoglycosides","volume":"7","author":"Bera","year":"2016","journal-title":"Med. Chem. Comm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1039\/C7CS00407A","article-title":"Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities","volume":"47","author":"Chandrika","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1039\/C4MD00163J","article-title":"New trends in the use of aminoglycosides","volume":"5","author":"Fosso","year":"2014","journal-title":"Med. Chem. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Bellucci, M.C., and Volonterio, A. (2020). Aminoglycosides: From Antibiotics to Building Blocks for the Synthesis and Development of Gene Delivery Vehicles. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080504"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cber.19510840306","article-title":"Pikromycin, ein bitter schmeckendes antibioticum aus actinomyeceten","volume":"84","author":"Brockmann","year":"1951","journal-title":"Chem. Ber."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(01)00401-0","article-title":"Macrolides: Structures and microbial targets","volume":"18","author":"Retsema","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Jedna\u010dak, T., Mikulandra, I., and Novak, P. (2020). Advanced Methods for Studying Structure and Interactions of Macrolide Antibiotics. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21207799"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1111\/bph.13936","article-title":"The macrolide antibiotic renaissance","volume":"174","author":"Dinos","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Undheim, K. (2020). Scaffold Modifications in Erythromycin Macrolide Antibiotics. A Chemical Minireview. Molecules, 25.","DOI":"10.3390\/molecules25173941"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1021\/acs.accounts.1c00020","article-title":"Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens","volume":"54","author":"Myers","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acsinfecdis.7b00258","article-title":"Developments in Glycopeptide Antibiotics","volume":"4","author":"Blaskovich","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F","article-title":"Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics","volume":"38","author":"Nicolaou","year":"1999","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/cr030103a","article-title":"Glycopeptide and lipoglycopeptide antibiotics","volume":"105","author":"Kahne","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1039\/D1CC06635H","article-title":"Pursuit of next-generation glycopeptides: A journey with vancomycin","volume":"58","author":"Acharya","year":"2022","journal-title":"Chem. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/ja.2014.111","article-title":"Glycopeptide antibiotics: Back to the future","volume":"67","author":"Butler","year":"2014","journal-title":"J. Antibiot."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jm01240a021","article-title":"1,8-Naphthyridine Derivatives: A New Class of Chemotherapeutic Agents","volume":"91","author":"Lesher","year":"1962","journal-title":"J. Med. Pharm. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/dkg208","article-title":"The quinolones: Decades of development and use","volume":"51","author":"Emmerson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Sharma, V., Das, R., Metha, D.K., Sharma, D., Aman, S., and Khan, M.U. (Mol. Divers., 2024). Quinolone scaffolds as potential drug candidates against infectious microbes: A review, Mol. Divers., online ahead of print.","DOI":"10.1007\/s11030-024-10862-4"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/cbdd.14025","article-title":"Emerging quinoline- and quinolone-based antibiotics in the light of epidemics","volume":"100","author":"Kaur","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"74 Bulet, P., St\u00f6cklin, R., and Menin, L. (2004). Anti-microbial peptides: From invertebrates to vertebrates. Immunol. Rev., 198, 169\u2013184.","DOI":"10.1111\/j.0105-2896.2004.0124.x"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"100954","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"115377","DOI":"10.1016\/j.ejmech.2023.115377","article-title":"Antimicrobial peptides: Structure, mechanism, and modification","volume":"255","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"79 Fel\u00edcio, M.R., Silva, O.N., Gon\u00e7alves, S., Santos, N.C., and Franco, O.L. (2017). Peptides with dual antimicrobial and anticancer activities. Front. Chem., 5.","DOI":"10.3389\/fchem.2017.00005"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"80 Ghimire, J., Hart, R.J., Soldano, A., Chen, C.H., Guha, S., Hoffmann, J.P., and Wimley, W.C. (2003). Optimization of host cell-compatible, antimicrobial peptides effective against biofilms and clinical isolates of drug-resistant bacteria. ACS Infect. Dis., 9, 952\u2013965.","DOI":"10.1021\/acsinfecdis.2c00640"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/jam.15314","article-title":"Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds","volume":"132","author":"Kesmen","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Chen, C.H., and Lu, T.K. (2020). Development and challenges of antimicrobial peptides for therapeutic applications. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010024"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1039\/D0CS00729C","article-title":"The multifaceted nature of antimicrobial peptides: Current synthetic chemistry approaches and future directions","volume":"50","author":"Gan","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Madani, F., Lindberg, S., Langel, U., Futaki, S., and Graslund, A. (2011). Mechanisms of cellular uptake of cell-penetrating peptides. Biophys. J., 414.","DOI":"10.1155\/2011\/414729"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_85","unstructured":"L\u00f3pez-Meza, J.E., Ochoa-Zarzosa, A., Aguilar, J.A., and Loeza-Lara, P.D. (2011). Antimicrobial peptides: Diversity and perspectives for their biomedical application. Biomedical Engineering, Trends, Research and Technologies, IntechOpen Limited."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pbiomolbio.2018.08.006","article-title":"Peptide based antimicrobials: Design strategies and therapeutic potential","volume":"142","author":"Hazam","year":"2018","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Benfield, A.H., and Henriques, S.T. (2020). Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms. Front. Med. Technol., 2.","DOI":"10.3389\/fmedt.2020.610997"},{"key":"ref_89","first-page":"808","article-title":"Interaction between antimicrobial peptides and DNA: Mechanism of action and application in biotechnology","volume":"34","author":"Miao","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"ref_90","unstructured":"Schenckbecher, K., Meyer, A., and Ennifar, E. (2019). Antibiotics targeting the ribosome. Ribosome Structure and Function, Springer."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"92 Helmerhorst, E.J., Troxler, R.F., and Oppenheim, F.G. (2001). The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA, 98, 14637\u201314642.","DOI":"10.1073\/pnas.141366998"},{"key":"ref_92","first-page":"43","article-title":"Antimicrobial peptide from Bacillus subtilis CSB138: Characterization, killing kinetics, and synergistic potency","volume":"20","author":"Regmi","year":"2017","journal-title":"Int. Microbiol."},{"key":"ref_93","first-page":"87","article-title":"Synergy between conventional antibiotics and antimicrobial peptides in the treatment of chronic bacterial infections","volume":"71","author":"Pletzer","year":"2018","journal-title":"J. Antibiot."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3892\/etm.2013.1231","article-title":"Synergistic effect of clinically used antibiotics and peptide antibiotics against Gram-positive and Gram-negative bacteria","volume":"6","author":"Zhou","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/mp9000662","article-title":"Biophysical interactions with model lipid membranes: Applications in drug discovery and drug delivery","volume":"6","author":"Peetla","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41467-017-02123-w","article-title":"Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria","volume":"9","author":"Blaskovich","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1002\/anie.202002727","article-title":"Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides","volume":"59","author":"Domhan","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2006.11.016","article-title":"Use of Hecate chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors","volume":"269","author":"Vuorenoja","year":"2007","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/IDR.S160975","article-title":"Novel vancomycin\u2013peptide conjugate as potent antibacterial agent against vancomycin-resistant Staphylococcus aureus","volume":"11","author":"Jelinkova","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cb0500015","article-title":"Redefining the requisite lipopolysaccharide structure in Escherichia coli","volume":"1","author":"Meredith","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1128\/AAC.48.9.3349-3357.2004","article-title":"De novo design of potent antimicrobial peptides","volume":"48","author":"Frecer","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Shi, W., Chen, F., Zou, X., Jiao, S., Wang, S., Hu, Y., Lan, L., Tang, F., and Huang, W. (2021). Design, synthesis, and antibacterial evaluation of vancomycin-LPS binding peptide conjugates. Bioorg. Chem. Med. Lett., 45.","DOI":"10.1016\/j.bmcl.2021.128122"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1476-5381.1967.tb01946.x","article-title":"Sodium sulphomethyl derivatives of polymyxins","volume":"29","author":"Beveridge","year":"1967","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"ref_104","first-page":"2480","article-title":"b-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria","volume":"2","author":"Desgranges","year":"2012","journal-title":"RCS Adv."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e24059","DOI":"10.1002\/pep2.24059","article-title":"Covalent conjugation of cationic antimicrobial peptides with b-lactam antibiotic core","volume":"110","author":"Li","year":"2018","journal-title":"Pept. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acsinfecdis.2c00406","article-title":"Development of antimicrobial peptide-antibiotic conjugates to improve the outer membrane permeability of antibiotics against Gram-negative bacteria","volume":"8","author":"Yamauchi","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.micro.55.1.21","article-title":"Roles of thiol-redox pathways in bacteria","volume":"55","author":"Ritz","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1021\/acsinfecdis.0c00387","article-title":"Improvement of therapeutic index by the combination of enhanced peptide cationicity and proline introduction","volume":"6","author":"Azuma","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1021\/jm100378b","article-title":"Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): A novel antibacterial peptide optimized against gram-negative human pathogens","volume":"53","author":"Knappe","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1021\/nn502201a","article-title":"Engineering persister-specific antibiotics with synergistic antimicrobial functions","volume":"8","author":"Schmidt","year":"2014","journal-title":"ACS Nano"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/jid.2015.40","article-title":"Pentobra: A Potent Antibiotic with Multiple Layers of Selective Antimicrobial Mechanisms against Propionibacterium Acnes","volume":"135","author":"Schmidt","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"19207","DOI":"10.1021\/ja308459j","article-title":"Molecular basis for nanoscopic membrane curvature generation from quantum mechanical models and synthetic transporter sequences","volume":"134","author":"Schmidt","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/acs.bioconjchem.6b00725","article-title":"Designing hybrid antibiotic peptide conjugates to cross bacterial membranes","volume":"28","author":"Deshayes","year":"2017","journal-title":"Bioconjugate Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrmicro3420","article-title":"Salmonellae interactions with host processes","volume":"13","author":"LaRock","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"9664","DOI":"10.1002\/anie.201302693","article-title":"Targeting Intracellular Pathogenic Bacteria with Unnatural Proline-Rich Peptides: Coupling Antibacterial Activity with Macrophage Penetration","volume":"52","author":"Kuriakose","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1021\/jacs.6b04831","article-title":"Dual Targeting of Intracellular Pathogenic Bacteria with a Cleavable Conjugate of Kanamycin and an Antibacterial Cell-Penetrating Peptide","volume":"138","author":"Brezden","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bbagen.2017.01.029","article-title":"Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate","volume":"1861","author":"Mohamed","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00018-011-0721-7","article-title":"Proline-Rich Antimicrobial Peptides: Converging to a Non-Lytic Mechanism of Action","volume":"68","author":"Scocchi","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/jm501367p","article-title":"Effect of Size and N-Terminal Residue Characteristics on Bacterial Cell Penetration and Antibacterial Activity of the Proline-Rich Peptide Bac7","volume":"58","author":"Guida","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1021\/acs.bioconjchem.2c00467","article-title":"Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin","volume":"34","author":"Gambato","year":"2023","journal-title":"Bioconjugate Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1039\/C4CS00246F","article-title":"Peptide stapling techniques based on different macrocyclisation chemistries","volume":"44","author":"Lau","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Louren\u00e7o, A.L.P., Rios, T.B., da Silva, A.P., Franco, O.L., and Ramada, M.H.S. (2023). Peptide Stapling Applied to Antimicrobial Peptides. Antibiotics, 12.","DOI":"10.3390\/antibiotics12091400"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Wojciechowska, M., Macyszyn, J., Miszkiewicz, J., Grzela, R., and Trylska, J. (2021). Stapled Anoplin as an Antibacterial Agent. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.772038"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"19047","DOI":"10.1021\/acsomega.3c02071","article-title":"Conjugates of Aminoglycosides with Stapled Peptides as a Way to Target Antibiotic-Resistant Bacteria","volume":"8","author":"Macyszyn","year":"2023","journal-title":"ACS Omega"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1242\/jcs.063016","article-title":"A newly identified bacterial cell-penetrating peptide that reduces the transcription of pro-inflammatory cytokines","volume":"123","author":"Buss","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e02545-16","DOI":"10.1128\/AAC.02545-16","article-title":"Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens","volume":"61","author":"Gomarasca","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.resmic.2012.06.001","article-title":"Synergistic effect of antimicrobial peptide arenicin-1 in combination with antibiotics against pathogenic bacteria","volume":"163","author":"Choi","year":"2012","journal-title":"Res. Microbiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00284-014-0529-4","article-title":"In vitro synergistic activities of antimicrobial peptide brevinin 2CE with five kinds of antibiotics against multidrug-resistant clinical isolates","volume":"68","author":"Zhang","year":"2014","journal-title":"Curr. Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1016\/S0021-9258(18)42830-X","article-title":"Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils","volume":"267","author":"Selsted","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1567201811666140910094050","article-title":"Levofloxacin and indolicidin for combination antimicrobial therapy","volume":"12","author":"Ghaffar","year":"2015","journal-title":"Curr. Drug Del."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijantimicag.2010.08.020","article-title":"Fungicidal Activity of Human Lactoferrin-Derived Peptides Based on the Antimicrobial A\u03b2 Region","volume":"37","author":"Kondori","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_134","first-page":"2233","article-title":"Antibiotic-Based Conjugates Containing Antimicrobial HLopt2Peptide: Design, Synthesis, Antimicrobial and Cytotoxic Activities","volume":"14","author":"Gucwa","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1166\/jbn.2014.1852","article-title":"In vivo imaging of infection using a bacteria-targeting optical nanoprobe","volume":"10","author":"Tang","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Dinos, G.P., Athanassopoulos, C.M., Missiri, D.A., Giannopoulou, P.C., Vlachogiannis, I.A., Papadopoulos, G.E., Papaioannou, D., and Kalpaxis, D.L. (2016). Chloramphenicol Derivatives as Antibacterial and Anticancer Agents: Historic Problems and Current Solutions. Antibiotics, 5.","DOI":"10.3390\/antibiotics5020020"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00259-012-2327-1","article-title":"Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29\u221241) in the diagnosis of diabetic foot infection","volume":"40","author":"Saeed","year":"2013","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1021\/acs.molpharmaceut.5b00053","article-title":"Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1021\/jm034233n","article-title":"Synthesis and Antibacterial Activity of a Novel Class of 4\u2018-Substituted 16-Membered Ring Macrolides Derived from Tylosin","volume":"47","author":"Phan","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nsmb.3034","article-title":"The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex","volume":"22","author":"Seefeldt","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_141","first-page":"871","article-title":"Conjugates of Desmycosin with Fragments of Antimicrobial Peptide Oncocin: Synthesis, Antibacterial Activity, Interaction with Ribosome","volume":"87","author":"Khairullina","year":"2022","journal-title":"Biochemistry"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/8\/783\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:40:36Z","timestamp":1760110836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/8\/783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":141,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["antibiotics13080783"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13080783","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}